Retrospective nationwide survey of acute stroke due to large vessel occlusion in japan: A review of 1,963 patients and the impact of endovascular treatment

Cerebrovascular Diseases

Volumn 32, Issue 3, 2011, Pages 219-226

  Yoshimura, Shinichi ^a   Egashira, Yusuke ^a   Sakai, Nobuyuki ^b   Kuwayama, Naoya ^c  

^a GIFU UNIVERSITY   (Japan)

^b KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Acute stroke; Endovascular therapy; Recanalization; Tissue plasminogen activator

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE STROKE; AGE DISTRIBUTION; AGED; ANGIOPLASTY; BASILAR ARTERY; BLOOD CLOT LYSIS; BLOOD VESSEL OCCLUSION; CLINICAL ASSESSMENT TOOL; CONSERVATIVE TREATMENT; ENDOVASCULAR SURGERY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTERNAL CAROTID ARTERY; JAPAN; LARGE VESSEL OCCLUSION; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY; PRIORITY JOURNAL; RECANALIZATION; RETROSPECTIVE STUDY; REVIEW; STROKE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR AGENTS; CAROTID STENOSIS; CHI-SQUARE DISTRIBUTION; CHILD; COMBINED MODALITY THERAPY; ENDOVASCULAR PROCEDURES; FEMALE; HEALTH CARE SURVEYS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; JAPAN; MALE; MIDDLE AGED; ODDS RATIO; PATIENT SELECTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME; VERTEBROBASILAR INSUFFICIENCY; YOUNG ADULT;

EID: 80051786729     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000328873     Document Type: Review

References (26)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587.
2. Yamaguchi T, Mori E, Minematsu K, Nakagawara J, Hashi K, Saito I, Shinohara Y, Japan Alteplase Clinical Trial (J-ACT) Group: Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke 2006; 37: 1810-1815. (Pubitemid 44297734)
3. Christou I, Alexandrov AV, Burgin WS, Wojner AW, Felberg RA, Malkoff M, Grotta JC: Timing of recanalization after tissue plasminogen activator therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke. Stroke 2000; 31: 1812-1816. (Pubitemid 30620455)
4. Labiche LA, Al-Senani F, Wojner AW, Grotta JC, Malkoff M, Alexandrov AV: Is the benefit of early recanalization sustained at 3 months? A prospective cohort study. Stroke 2003; 34: 695-698. (Pubitemid 36307395)
5. Lee KY, Han SW, Kim SH, Nam HS, Ahn SW, Kim DJ, Seo SH, Kim DI, Heo JH: Early recanalization after intravenous administration of recombinant tissue plasminogen activator as assessed by pre-and post-thrombolytic angiography in acute ischemic stroke patients. Stroke 2007; 38: 192-193. (Pubitemid 46035627)
6. Rha JH, Saver JL: The impact of recanalization on ischemic stroke outcome: A metaanalysis. Stroke 2007; 38: 967-973. (Pubitemid 46568460)
7. Ribo M, Alvarez-Sabin J, Montaner J, Romero F, Delgado P, Rubiera M, Delgado-Mederos R, Molina CA: Temporal profile of recanalization after intravenous tissue plasminogen activator: Selecting patients for rescue reperfusion techniques. Stroke 2006; 37: 1000-1004.
8. Ringelstein EB, Biniek R, Weiller C, Ammeling B, Nolte PN, Thron A: Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization. Neurology 1992; 42: 289-298.
9. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F: Intraarterial prourokinase for acute ischemic stroke: The PROACT II study: A randomized controlled trial. JAMA 1999; 282: 2003-2011.
10. Ogawa A, Mori E, Minematsu K, Taki W, Takahashi A, Nemoto S, Miyamoto S, Sasaki M, Inoue T: Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: The middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007; 38: 2633-2639. (Pubitemid 47493996)
11. Kim DJ, Kim DI, Kim SH, Lee KY, Heo JH, Han SW: Rescue localized intra-arterial thrombolysis for hyperacute MCA ischemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy. Neuroradiology 2005; 47: 616-621. (Pubitemid 41258711)
12. Lansberg MG, Fields JD, Albers GW, Jayaraman MV, Do HM, Marks MP: Mechanical thrombectomy following intravenous thrombolysis in the treatment of acute stroke. Arch Neurol 2005; 62: 1763-1765. (Pubitemid 41626675)
13. Lewandowski CA, Frankel M, Tomsick TA, Broderick J, Frey J, Clark W, Starkman S, Grotta J, Spilker J, Khoury J, Brott T: Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999; 30: 2598-2605.
14. Qureshi AI, Janjua N, Kirmani JF, Harris-Lane P, Suri MF, Zhou J, Divani AA: Mechanical disruption of thrombus following intravenous tissue plasminogen activator for ischemic stroke. J Neuroimaging 2007; 17: 124-130. (Pubitemid 46624153)
15. Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP, Lutsep HL, Nesbit GM, Grobelny T, Rymer MM, Silverman IE, Higashida RT, Budzik RF, Marks MP, MERCI Trial Investigators: Safety and efficacy of mechanical embolectomy in acute ischemic stroke: Results of the MERCI trial. Stroke 2005; 36: 1432-1438. (Pubitemid 40967507)
16. Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS, Lutsep HL, Rymer MM, Higashida RT, Starkman S, Gobin YP: Mechanical thrombectomy for acute ischemic stroke: Final results of the Multi MERCI trial. Stroke 2008; 39: 1205-1212. (Pubitemid 351440692)
17. Penumbra Pivotal Stroke Trial Investigators: The penumbra pivotal stroke trial: Safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009; 40: 2761-2768.
18. Sugiura S, Iwaisako K, Toyota S, Takimoto H: Simultaneous treatment with intravenous recombinant tissue plasminogen activator and endovascular therapy for acute ischemic stroke within 3 h of onset. AJNR Am J Neuroradiol 2008; 29: 1061-1066. (Pubitemid 351954867)
19. Yoshimura S, Enomoto Y, Yamada K, Iwama T: Initial experience of balloon catheter disruption of the thrombus in an unrecanalized intracranial artery after intravenous recombinant tissue plasminogen activator. JNET 2008; 2: 207-211.
20. Khatri P, Hill MD, Palesch YY, Spilker J, Jauch EC, Carrozzella JA, Demchuk AM, Martin R, Mauldin P, Dillon C, Ryckborst KJ, Janis S, Tomsick TA, Broderick JP, Interventional Management of Stroke III Investigators: Methodology of the Interventional Management of Stroke III Trial. Int J Stroke 2008; 3: 130-137. (Pubitemid 351566847)
21. The Thrombolysis in Myocardial Infarction (TIMI) trial: Phase I findings. TIMI Study Group. N Engl J Med 1985; 312: 932-936.
22. Pfefferkorn T, Holtmannspötter M, Schmidt C, Bender A, Pfister HW, Straube A, Mayer TE, Brückmann H, Dichgans M, Fesl G: Drip, ship, and retrieve: Cooperative recanalization therapy in acute basilar artery occlusion. Stroke 2010; 41: 722-726.
23. Mori E, Minematsu K, Nakagawara J, Yamaguchi T, Sasaki M, Hirano T, for the J-ACT II Group: Effects of 0.6 mg/kg intravenous alteplase on vascular and clinical outcomes in middle cerebral artery occlusion Japan Alteplase Clinical Trial II (J-ACT II). Stroke 2010; 41: 461-465.
24. Hirano T, Sasaki M, Mori E, Minematsu K, Nakagawara J, Yamaguchi T, for the Japan Alteplase Clinical Trial II Group: Residual vessel length on magnetic resonance angiography identifies poor responders to alteplase in acute middle cerebral artery occlusion patients. Exploratory analysis of the Japan Alteplase Clinical Trial II. Stroke 2010; 41: 2828-2833.
25. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D, ECASS Investigators: Thrombolysis with alteplase 3 to 4.5 h after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329.
26. Aoki J, Kimura K, Iguchi Y, Shibazaki K, Iwanaga T, Watanabe M, Kobayashi K, Sakai K, Sakamoto Y: Intravenous thrombolysis based on diffusion-weighted imaging and fluid-attenuated inversion recovery mismatch in acute stroke patients with unknown onset time. Cerebrovasc Dis 2011; 31: 435-441.